3,5-Dimethyl-4-nitropyridine N-Oxide

Product Overview

3,5-Dimethyl-4-nitropyridine N-Oxide, identified by CAS number 14248-66-9, is a specialized heterocyclic compound widely recognized in the pharmaceutical industry for its pivotal role in organic synthesis. This chemical serves as a fundamental building block for the production of various proton pump inhibitors (PPIs), which are essential therapeutic agents used globally for managing gastrointestinal disorders. Our manufacturing process ensures that every batch meets stringent quality standards, providing reliability for downstream API synthesis.

As a leading supplier in the fine chemicals sector, we understand the critical nature of purity and consistency in pharmaceutical intermediates. This compound is characterized by its distinct bright yellow crystalline powder appearance and stable chemical properties, making it an ideal candidate for complex multi-step synthesis routes. We employ advanced analytical techniques to verify molecular structure and impurity profiles, ensuring that our clients receive materials that facilitate efficient reaction yields and high-quality final products.

Technical Specifications

Quality control is paramount in the production of pharmaceutical intermediates. The following table outlines the key physical and chemical parameters verified during our standard quality assurance protocols. Each certificate of analysis (COA) provided with shipment reflects these specifications to guarantee transparency and compliance with industry expectations.

Industrial Applications

The primary application of 3,5-Dimethyl-4-nitropyridine N-Oxide lies in the pharmaceutical sector, specifically as a key synthon for the manufacture of proton pump inhibitor APIs. It is extensively utilized in the synthesis pathways of well-known medications such as Omeprazole, Pantoprazole, and Rabeprazole. These final therapeutic products are crucial for treating conditions like gastroesophageal reflux disease (GERD) and peptic ulcers.

For chemical manufacturers and research laboratories, this intermediate offers a robust starting point for constructing the pyridine core required in these drug molecules. Its high purity level minimizes the need for extensive purification steps later in the synthesis process, thereby optimizing production costs and reducing waste. We support both large-scale commercial production and smaller-scale research initiatives, providing flexible packaging solutions to meet diverse operational needs.

Storage and Handling

To maintain the integrity and stability of 3,5-Dimethyl-4-nitropyridine N-Oxide, proper storage conditions are essential. The material should be kept in a cool, dry, and well-ventilated area, strictly away from direct sunlight and sources of intense heat. Containers must remain tightly sealed to prevent moisture absorption, which could affect the loss on drying specifications and overall reactivity.

When handling this chemical, standard laboratory safety protocols should be followed. Personnel are advised to use appropriate personal protective equipment, including gloves and safety goggles, to avoid direct contact with skin or eyes. In case of spills, standard chemical cleanup procedures should be implemented immediately. By adhering to these guidelines, users can ensure safe handling while preserving the high quality of the material for their synthesis projects.